Accelerbiotics® was founded April 2019 as spinout from Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark.
We have addressed the huge bottlenecks of low-throughput, high-cost and sustainability issues associated with applications of electrophoresis, purification/extraction and electrotransfection/electroporation in the biotechnology field.
Our technologies provide affordable solutions that accelerate the throughput and performance in synthetic biology and in the biotech industry providing sustainable microbial cell factories.
We have developed the following three technologies and protected them with two patent families:
1. high-throughput electrophoresis with online real-time analysis of DNA/RNA/proteins/amino acids/sugars
2. high-throughput sustainable purification of DNA/RNA/proteins/amino acids/sugars.
3. high-throughput sustainable electrotransfection and electro-extraction.